Easier cure for resistant TB

Science. 2017 Feb 17;355(6326):677. doi: 10.1126/science.355.6326.677.
No abstract available

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / microbiology
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use*
  • Baltimore
  • Clinical Trials as Topic
  • Diarylquinolines / administration & dosage
  • Diarylquinolines / therapeutic use*
  • Drug Therapy, Combination
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / microbiology
  • Humans
  • Linezolid / administration & dosage
  • Linezolid / therapeutic use*
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / isolation & purification
  • Nitroimidazoles / administration & dosage
  • Nitroimidazoles / therapeutic use*
  • South Africa
  • Sputum / microbiology
  • Treatment Outcome

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Nitroimidazoles
  • pretomanid
  • bedaquiline
  • Linezolid